Ainos, Inc., a healthcare company, is dedicated to the development of medical technologies for safe and novel point-of-care testing and medical treatment for disease indications. The company is headquartered in San Diego, California.
| Revenue (TTM) | 124,160 |
| Gross Profit (TTM) | 102,910 |
| EBITDA | $-9.21M |
| Operating Margin | -38648.00% |
| Return on Equity | -128.00% |
| Return on Assets | -35.20% |
| Revenue/Share (TTM) | $0.03 |
| Book Value | $1.29 |
| Price-to-Book | 1.38 |
| Price-to-Sales (TTM) | 87.20 |
| EV/Revenue | 169.51 |
| EV/EBITDA | -1.60 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 412.40% |
| Shares Outstanding | $7.27M |
| Float | $3.24M |
| % Insiders | 58.72% |
| % Institutions | 3.42% |